Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: episodic (5), intermittent (36), sporadic (4)

Capecitabine-Cisplatin

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE and CISPLATIN Regimen • Gastrointestinal Cancer (upper) – Capecitabine and Cisplatin Indication • First line therapy of inoperable
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin.pdf

Capecitabine-Gemcitabine

Description: Chemotherapy Protocol PANCREATIC CANCER CAPECITABINE and GEMCITABINE Regimen • Pancreatic Cancer– Capecitabine-Gemcitabine Indication • Adjuvant treatment of pancreatic cancer • First line treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Pancreas/Capecitabine-Gemcitabine.pdf

Capecitabine-Oxaliplatin

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and OXALIPLATIN (CAPOX) Regimen • Colorectal Cancer – Capecitabine-Oxaliplatin (CAPOX) Indication • Advanced / metastatic colorectal cancer • Adjuvant therapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Oxaliplatin.pdf

Capecitabine-Irinotecan

Description: Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE and IRINOTECAN (XELIRI) Regimen • Colorectal Cancer– Capecitabine-Irinotecan (XELIRI) Indication • Treatment of advanced colorectal cancer • WHO
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Irinotecan.pdf

Bevacizumab-Capecitabine

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-CAPECITABINE This protocol may require funding Regimen • Colorectal Cancer– Bevacizumab-Capecitabine Indication • The first line treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Capecitabine.pdf

Capecitabine-Streptozocin

Description: Chemotherapy Protocol NEUROENDOCRINE CAPECITABINE-STREPTOZOCIN Regimen • Neuroendocrine – Capecitabine-Streptozocin Indication • Metastatic or locally advance neuroendocrine tumours irrespective of primary site, predominantly
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Capecitabine-Streptozocin.pdf

Capecitabine-Cisplatin-Trastuzumab

Description: Chemotherapy Protocol GASTROINTESTINAL (UPPER) CANCER CAPECITABINE-CISPLATIN-TRASTUZUMAB Regimen • Gastrointestinal (Upper) Cancer – Capecitabine-Cisplatin-Trastuzumab Indication • Trastuzumab, in combination with capecitabine
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Upper-gastro-intestinal/Capecitabine-Cisplatin-Trastuzumab.pdf

Carfilzomib(14 day)-Dexamethasone(20) Ver1

Description: Chemotherapy Protocol MYELOMA Carfilzomib (14 day)-Dexamethasone (20) Regimen  Myeloma – Carfilzomib-Dexamethasone (20)
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/carfilzomib14-day-dexamethasone20-ver1.pdf

Bevacizumab-Capecitabine-Oxaliplatin

Description: Chemotherapy Protocol COLORECTAL CANCER BEVACIZUMAB-CAPECITABINE-OXALIPLATIN This protocol may require funding Regimen • Colorectal Cancer– Bevacizumab-Capecitabine-Oxaliplatin Indication • Metastatic colorectal
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Bevacizumab-Capecitabine-Oxaliplatin.pdf

Gilteritinib

Description: Chemotherapy Protocol Acute Myeloid Leukaemia GILTERITINIB Regimen  AML - Gilteritinib Indication Gilteritinib for treating relapsed/refractory FLT3 mutation positive myeloid leukaemia in
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Gilteritinib.pdf

41 to 50 of 187

Previous … 3 4 5 6 7 … Next